Bonnie L. Bassler - 07 Apr 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Issuer symbol
REGN
Transactions as of
07 Apr 2022
Net transactions value
-$426,622
Form type
4
Filing time
11 Apr 2022, 16:38:35 UTC
Previous filing
01 Apr 2022
Next filing
24 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $472,378 +1,240 +115% $380.95 2,322 07 Apr 2022 Direct F1
transaction REGN Common Stock Sale $899,000 -1,240 -53% $725.00 1,082 07 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,240 -20% $0.000000 4,959 07 Apr 2022 Common Stock 1,240 $380.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.